PSA and PSA Kinetics as Predictors for 18F-Fluciclovine PET/CT Positivity in Biochemically Recurrent Prostate Cancer

Conclusion: PSA and PSA kinetics are unlikely to be associated with18F-fluciclovine PET/CT positivity in patients with BCR, and none of these serum biomarkers might be used as single predictors of PET/CT detection. Larger studies might be needed to evaluate the role of different predictors.Urol Int
Source: Urologia Internationalis - Category: Urology & Nephrology Source Type: research